1. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Issue 1 (January 2023) Authors: Solomon, Joshua J; Danoff, Sonye K; Woodhead, Felix A; Hurwitz, Shelley; Maurer, Rie; Glaspole, Ian; Dellaripa, Paul F; Gooptu, Bibek; Vassallo, Robert; Cox, P Gerard; Flaherty, Kevin R; Adamali, Huzaifa I; Gibbons, Michael A; Troy, Lauren; Forrest, Ian A; Lasky, Joseph A; Spencer, Lisa G; Golden... Journal: Lancet Issue: Volume 11:Issue 1(2023) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗